Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference

GlobeNewswire05:01

ARKK's Holdings Ranked by SA Quant Grades

Seeking Alpha03:21

CRISPR, Beam, Other Gene Editing Names up Significantly

Seeking AlphaNov 12 02:15

Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing

MT NewswiresNov 9 05:23

Beam Therapeutics Gets Upgrade From Leerink Partners; Shares Rise

MT NewswiresNov 7 03:26

H.C. Wainwright Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $80

Futu NewsNov 7 01:32 · Ratings